Chemours (CC) | Financial Analysis & Statements

Chemours Co. | Small-cap | Basic Materials

$12.42

-3.94%

Chemours vs Linde plc Chemours vs Sherwin-Williams Chemours vs Quaker Chemical Chemours vs Minerals Chemours vs Perimeter Solutions Chemours vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 5.8B

Gross Profit 1.2B 19.91%

Operating Income 443.0M 7.66%

Net Income 86.0M 1.49%

EPS (Diluted) $0.57

Balance Sheet Metrics

Total Assets 7.5B

Total Liabilities 6.9B

Shareholders Equity 605.0M

Debt to Equity 11.42

Cash Flow Metrics

Operating Cash Flow -692.0M

Free Cash Flow -993.0M

Revenue & Profitability Trend

Chemours Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	5.8B	6.0B	6.8B	6.3B	5.0B
Cost of Goods Sold	4.6B	4.7B	5.2B	5.0B	3.9B
Gross Profit	1.2B	1.3B	1.6B	1.4B	1.1B
Operating Expenses	708.0M	1.4B	830.0M	707.0M	661.0M
Operating Income	443.0M	-123.0M	786.0M	674.0M	406.0M
Pre-tax Income	127.0M	-318.0M	741.0M	676.0M	179.0M
Income Tax	41.0M	-81.0M	163.0M	68.0M	-40.0M
Net Income	86.0M	-237.0M	578.0M	608.0M	219.0M
EPS (Diluted)	$0.57	-$1.60	$3.65	$3.60	$1.32

Income Statement Trend

Chemours Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	3.0B	3.8B	3.2B	3.3B	2.6B
Non-Current Assets	4.5B	4.4B	4.4B	4.2B	4.4B
Total Assets	7.5B	8.3B	7.6B	7.6B	7.1B
Liabilities
Current Liabilities	1.8B	2.5B	1.9B	1.9B	1.4B
Non-Current Liabilities	5.1B	5.0B	4.6B	4.6B	4.8B
Total Liabilities	6.9B	7.5B	6.5B	6.5B	6.3B
Equity
Total Shareholders Equity	605.0M	739.0M	1.1B	1.1B	815.0M

Balance Sheet Composition

Chemours Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	86.0M	-237.0M	578.0M	608.0M	219.0M
Operating Cash Flow	-692.0M	645.0M	796.0M	913.0M	779.0M
Investing Activities
Capital Expenditures	-360.0M	-370.0M	-307.0M	-277.0M	-267.0M
Investing Cash Flow	-355.0M	-221.0M	-287.0M	220.0M	-234.0M
Financing Activities
Dividends Paid	-148.0M	-149.0M	-154.0M	-164.0M	-164.0M
Financing Cash Flow	-45.0M	153.0M	-737.0M	-577.0M	-887.0M
Free Cash Flow	-993.0M	186.0M	448.0M	537.0M	540.0M

Cash Flow Trend

Chemours Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 58.89

Forward P/E 4.59

Price to Book 2.74

Price to Sales 0.27

PEG Ratio 4.59

Profitability Ratios

Profit Margin 0.48%

Operating Margin 6.43%

Return on Equity 4.20%

Return on Assets 3.32%

Financial Health

Current Ratio 1.75

Debt to Equity 755.35

Beta 1.61

Per Share Data

EPS (TTM) $0.18

Book Value per Share $3.87

Revenue per Share $38.66

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
cc	1.6B	58.89	2.74	4.20%	0.48%	755.35
Linde plc	216.0B	33.33	5.69	17.01%	20.02%	60.56
Sherwin-Williams	86.6B	32.64	20.88	70.22%	11.63%	329.97
Quaker Chemical	2.0B	21.68	1.46	6.80%	5.20%	55.59
Minerals	1.7B	11.37	1.08	-1.18%	-1.14%	60.34
Perimeter Solutions	2.0B	14.62	1.63	11.76%	23.23%	66.33

Financial data is updated regularly. All figures are in the company's reporting currency.